Oncology
Commentary
The Urethra Is a Sex Organ; Why This Matters in Incontinence
The urethra is androgen dependent and plays a role in incontinence, explains Dr. Morey.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Feature
Higher Prostate Cancer Rates Seen in Black Men, but Advanced Cases Similar to White Men
Pros and cons of establishing different “normal” PSA levels for different races discussed.
Latest News
Latest NCCN Melanoma Guidelines Capture Dynamic of Constantly Evolving Best Practice
Many of the changes in the 2024 NCCN guidelines capture incremental advances rather than a radical departure from previous practice.
Feature
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
What are the cancer types where exercise makes a difference?
Feature
TIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?
Doctors are prepared to advocate for insurance coverage of the newly approved therapy on a case-by-case basis.
Latest News
How the Change Healthcare Cyberattack Affects Oncology Care
After a ransomware attack, Change Healthcare disconnected its online systems, and physicians have had to implement workarounds.
Latest News
Study Finds No Increased Cancer Risk With Spironolactone
Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
Latest News
Outside the Guidelines: Denosumab Overuse in Prostate Cancer
For patients with metastatic castration-sensitive disease the bone-modifying agents show no benefit in preventing skeletal-related events, are not...
Latest News
Older Age Confers a Higher Risk for Second Primary Melanoma: Study
Knowledge about one's risk for a second primary invasive melanoma over time remains incomplete.